Table 1 Clinicopathologic and demographic characteristics of BLCA patients in the training and test cohorts
Covariates | Type | Total | Test | Train | Pvalue |
|---|---|---|---|---|---|
Age | <=65 | 159(39.5%) | 84(41.8%) | 75(37.1%) | 0.4 |
> 65 | 244(60.6%) | 117(58.2%) | 127(62.9%) | ||
Gender | FEMALE | 106(26.3%) | 56(27.9%) | 50(24.8%) | 0.6 |
MALE | 297(73.7%) | 145(72.1%) | 152(75.3%) | ||
Grade | High Grade | 380(94.3%) | 187(93.0%) | 193(95.5%) | 0.5 |
Low Grade | 20(5.0%) | 12(6.0%) | 8(4.0%) | ||
unknow | 3(0.7%) | 2(1%) | 1(0.5%) | ||
Stage | Stage I | 2(0.5%) | 0(0%) | 2(1.0%) | 0.1 |
Stage II | 127(31.5%) | 71(35.3%) | 56(27.7%) | ||
Stage III | 140(34.7%) | 72(35.8%) | 68(33.7%) | ||
Stage IV | 132(32.8%) | 56(27.9%) | 76(37.6%) | ||
unknow | 2(0.5%) | 2(1.0%) | 0(0%) | ||
T | T1 | 3(0.8%) | 1(0.5%) | 2(1.0%) | 0.2 |
T2 | 117(29.0%) | 67(33.3%) | 50(24.8%) | ||
T3 | 193(47.9%) | 92(45.8%) | 101(50%) | ||
T4 | 57(14.1%) | 24(11.9%) | 33(16.3%) | ||
unknow | 33(8.2%) | 17(8.5%) | 16(7.9%) | ||
M | M0 | 194(48.1%) | 105(52.2%) | 89(44.1%) | 0.8 |
M1 | 11(2.7%) | 7(3.5%) | 4(2.0%) | ||
unknow | 198(49.2%) | 89(44.3%) | 109(53.9%) | ||
N | N0 | 234(58.1%) | 128(63.7%) | 106(52.5%) | 0.9 |
N1 | 46(11.4%) | 17(8.5%) | 29(14.4%) | ||
N2 | 75(18.6%) | 34(16.9%) | 41(20.3%) | ||
N3 | 6(1.5%) | 2(1%) | 4(1.9%) | ||
unknow | 42(10.4%) | 20(9.9%) | 22(10.9%) |